An assistant professor of finance at the University of Florida, Alejandro Lopez-Lira, has spent the past few years trying to ...

SentinelOne (S) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

PTC Therapeutics (PTCT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Bio-Techne faces significant macro and policy headwinds, including reduced academic research funding, China risks, and U.S.